Drug Search Results
More Filters [+]

Telenzepine

Alternative Names: telenzepine
Latest Update: 2024-04-20
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: M1 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Theracos
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Telenzepine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Obesity|Overweight

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

THR-4450-C-401

P1

Completed

Overweight|Obesity

2010-08-01

Recent News Events